Cargando…

Systematic tracking of altered modules identifies the key biomarkers involved in chronic lymphocytic leukemia

Key genes in chronic lymphocytic leukemia (CLL) were investigated through systematically tracking the dysregulated modules from protein-protein interaction (PPI) networks. Microarray data of normal subjects and CLL patients recruited from ArrayExpress database were applied to extract differentially...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Xin, Wu, Zhen, Zhao, Xue-Ying, Li, Chun-Feng, Kan, Shi-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341787/
https://www.ncbi.nlm.nih.gov/pubmed/30675301
http://dx.doi.org/10.3892/ol.2018.9812
_version_ 1783389016103583744
author Lu, Xin
Wu, Zhen
Zhao, Xue-Ying
Li, Chun-Feng
Kan, Shi-Feng
author_facet Lu, Xin
Wu, Zhen
Zhao, Xue-Ying
Li, Chun-Feng
Kan, Shi-Feng
author_sort Lu, Xin
collection PubMed
description Key genes in chronic lymphocytic leukemia (CLL) were investigated through systematically tracking the dysregulated modules from protein-protein interaction (PPI) networks. Microarray data of normal subjects and CLL patients recruited from ArrayExpress database were applied to extract differentially expressed genes (DEGs). Additionally, we re-weighted the PPI network of normal and CLL conditions by means of Pearsons correlation coefficient (PCC). Furthermore, clique-merging method was applied to extract the modules and then the altered modules were screened out. The intersection genes were selected from miss and add genes in the altered modules. The common genes were screened from the intersection genes and DEGs in CLL. A total of 734 DEGs were screened by statistical analysis. In this investigation, there were 1,805 and 703 modules in normal as well as disease PPI network. In addition, 875 altered modules were obtained which included 145 miss genes, 353 add genes and 85 intersection genes. Finally, in-depth analysis revealed 9 mutual genes between the intersection genes and DEGs in CLL. Our analysis revealed several key genes associated with CLL by systematically tracking the dysregulated modules, which might be candidate targets for diagnosis and management of CLL.
format Online
Article
Text
id pubmed-6341787
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-63417872019-01-23 Systematic tracking of altered modules identifies the key biomarkers involved in chronic lymphocytic leukemia Lu, Xin Wu, Zhen Zhao, Xue-Ying Li, Chun-Feng Kan, Shi-Feng Oncol Lett Articles Key genes in chronic lymphocytic leukemia (CLL) were investigated through systematically tracking the dysregulated modules from protein-protein interaction (PPI) networks. Microarray data of normal subjects and CLL patients recruited from ArrayExpress database were applied to extract differentially expressed genes (DEGs). Additionally, we re-weighted the PPI network of normal and CLL conditions by means of Pearsons correlation coefficient (PCC). Furthermore, clique-merging method was applied to extract the modules and then the altered modules were screened out. The intersection genes were selected from miss and add genes in the altered modules. The common genes were screened from the intersection genes and DEGs in CLL. A total of 734 DEGs were screened by statistical analysis. In this investigation, there were 1,805 and 703 modules in normal as well as disease PPI network. In addition, 875 altered modules were obtained which included 145 miss genes, 353 add genes and 85 intersection genes. Finally, in-depth analysis revealed 9 mutual genes between the intersection genes and DEGs in CLL. Our analysis revealed several key genes associated with CLL by systematically tracking the dysregulated modules, which might be candidate targets for diagnosis and management of CLL. D.A. Spandidos 2019-02 2018-12-07 /pmc/articles/PMC6341787/ /pubmed/30675301 http://dx.doi.org/10.3892/ol.2018.9812 Text en Copyright: © Lu et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Lu, Xin
Wu, Zhen
Zhao, Xue-Ying
Li, Chun-Feng
Kan, Shi-Feng
Systematic tracking of altered modules identifies the key biomarkers involved in chronic lymphocytic leukemia
title Systematic tracking of altered modules identifies the key biomarkers involved in chronic lymphocytic leukemia
title_full Systematic tracking of altered modules identifies the key biomarkers involved in chronic lymphocytic leukemia
title_fullStr Systematic tracking of altered modules identifies the key biomarkers involved in chronic lymphocytic leukemia
title_full_unstemmed Systematic tracking of altered modules identifies the key biomarkers involved in chronic lymphocytic leukemia
title_short Systematic tracking of altered modules identifies the key biomarkers involved in chronic lymphocytic leukemia
title_sort systematic tracking of altered modules identifies the key biomarkers involved in chronic lymphocytic leukemia
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341787/
https://www.ncbi.nlm.nih.gov/pubmed/30675301
http://dx.doi.org/10.3892/ol.2018.9812
work_keys_str_mv AT luxin systematictrackingofalteredmodulesidentifiesthekeybiomarkersinvolvedinchroniclymphocyticleukemia
AT wuzhen systematictrackingofalteredmodulesidentifiesthekeybiomarkersinvolvedinchroniclymphocyticleukemia
AT zhaoxueying systematictrackingofalteredmodulesidentifiesthekeybiomarkersinvolvedinchroniclymphocyticleukemia
AT lichunfeng systematictrackingofalteredmodulesidentifiesthekeybiomarkersinvolvedinchroniclymphocyticleukemia
AT kanshifeng systematictrackingofalteredmodulesidentifiesthekeybiomarkersinvolvedinchroniclymphocyticleukemia